Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Yashoda Medicity opens new 1,200-bed hospital in India 2. AJJ Healthcare secures supply contract with SG healthcare network 3. Medical Fair Thailand powers healthcare innovation through global collaboration 4. IJN, Myanmar hospital sign MoU on specialised paediatric cardiac care 5. First REIT renews short-term lease for Siloam Hospitals Lippo CikarangResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Partner Events
Nov
12
Event News
Be recognised as one of the region’s most exceptional healthcare providers and innovators.
